Skip to content

Quantbot Technologies LP: CMCSA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Quantbot Technologies LP on CMCSA, newest first. How the timeline and the estimate are built.

Quantbot Technologies LP held 128,809 CMCSA shares at 2026-06-30 per its 13F-HR filed 2026-08-12.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 128,809 shares
    Change vs previous 13F -133,435 shares

    0.12% of the 13F portfolio, value $3,162,261.

    13F-HR 0001512991-26-000004 filed by Quantbot Technologies LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 262,244 shares
    Change vs previous 13F +262,244 shares

    0.31% of the 13F portfolio, value $7,529,025.

    13F-HR 0001512991-26-000003 filed by Quantbot Technologies LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -112,273 shares

    13F-HR 0001512991-26-000002 filed by Quantbot Technologies LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2025-09-30
    13F 112,273 shares
    Change vs previous 13F -31,371 shares

    0.1% of the 13F portfolio, value $3,527,618.

    13F-HR 0001512991-25-000031 filed by Quantbot Technologies LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 143,644 shares
    Change vs previous 13F not available

    0.13% of the 13F portfolio, value $5,126,654.

    13F-HR 0001512991-25-000030 filed by Quantbot Technologies LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).